ArchiMed-backed NAMSA buys Clinlogix

NAMSA, which is backed by ArchiMed, has acquired Clinlogix, a provider of outsourced services for healthcare testing and clinical trials.

2 August 2021•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles